Meningococcal group B disease (Men B) News

After nearly 20 years of research and development, a vaccine for meningococcal group B disease (Men B) has been developed and licensed for use in the UK, yet it isn’t available on the NHS
In March 2014, the Joint Committee on Vaccination and Immunisation (JCVI), the independent expert group that advises UK governments on vaccination, recommended routine use of the first ever wide-ranging MenB (meningococcal B meningitis and septicaemia) vaccine.
Heathrow Medical travel clinic